Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin–gemcitabine–vinorelbine. A phase II study
Open Access
- 1 October 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 12 (10) , 1369-1374
- https://doi.org/10.1023/a:1012552525667
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyJournal of Clinical Oncology, 2000
- Randomized Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine With Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer: Interim Analysis of a Phase III Trial of the Southern Italy Cooperative Oncology GroupJournal of Clinical Oncology, 2000
- Paclitaxel in Advanced Non-Small Cell Lung CancerChest, 2000
- Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patientsCancer, 2000
- Gemcitabine and Cisplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Randomized Phase III Study of the Italian Lung Cancer ProjectJournal of Clinical Oncology, 1999
- Global cancer statisticsCA: A Cancer Journal for Clinicians, 1999
- MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungInternational Journal of Cancer, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- Reporting results of cancer treatmentCancer, 1981